Nanobiotix S.A.

NASDAQ: NBTX · Real-Time Price · USD
8.80
0.89 (11.25%)
At close: Aug 18, 2025, 11:44 AM

Nanobiotix S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-46.26M -21.87M -11.6M -28.1M -30.68M -26.36M -16.58M -30.42M
Depreciation & Amortization
835K 786K 772K 740K 754K 746K 759K 801K
Stock-Based Compensation
2.36M 1.94M 1.95M 674.5K 957K 680K 901.5K 699K
Other Working Capital
14.21M -279K 1.09M -570K -642K 1.86M -125K 14.99M
Other Non-Cash Items
12.47M 15.8M 12.4M -665K 13.89M 3.25M -2.24M 11.59M
Deferred Income Tax
101K n/a n/a -180K -3.39M -116K n/a n/a
Change in Working Capital
16.78M -2.49M 1.27M 5.68M -1.62M 3.92M 1.94M 9.6M
Operating Cash Flow
-13.71M -5.84M 4.8M -17.58M -20.14M -17.88M -15.58M -15.42M
Capital Expenditures
-359K -489K -5K -324K -14K -79K -183K -50K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -18K -3K n/a n/a -9K n/a
Sales Maturities Of Investments
n/a n/a n/a n/a 98K 133K n/a n/a
Other Investing Acitivies
-98K -11K -17K -2K 49K 66K -4.5K -2.5K
Investing Cash Flow
-455K -500K -22K -327K 85K 53K -192K -50K
Debt Repayment
-4.16M n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.68M -2.65M 48.91M -1.84M -1.59M -3.15M -1.74M -1.35M
Financial Cash Flow
-2.48M -2.65M 48.91M -1.84M -1.59M -3.15M -2.7M -1.35M
Net Cash Flow
54.21M -4.47M 53.65M -16.95M -24.45M -20.9M -18.41M -16.82M
Free Cash Flow
-14.07M -6.33M 4.79M -17.9M -20.16M -17.96M -15.77M -15.47M